Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 2/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.32 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 3/20 | 0.30 |
| ▸ | PGK2 | P07205 | 3/20 | 0.30 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.30 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4409893 | 0.78 | — | — | |
| SCHEMBL1584494 | 0.72 | — | — | |
| SCHEMBL10425747 | 0.67 | — | — | |
| Phosphoric Acid SCHEMBL27971573 | 0.66 | CA2 (0.50) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Phosphoric Acid SCHEMBL83112 | 0.66 | — | — | |
| Phosphoric Acid SCHEMBL9617774 | 0.66 | CA2 (0.50) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Phosphoric Acid SCHEMBL4294414 | 0.66 | CA2 (0.50) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Phosphoric Acid SCHEMBL27941021 | 0.66 | — | — | |
| SCHEMBL919194 | 0.64 | — | — | |
| SCHEMBL1409859 | 0.64 | KDM4E (0.43) | KDM4EMMP2THRBMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118146259-A | Iron ion stabilizer for oilfield acidification and synthesis method thereof | 山东滨州昱诚化工科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117430634-A | Iron ion stabilizer for acidizing and fracturing and preparation method thereof | 滨州市广友石油科技有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-118146259-A | Iron ion stabilizer for oilfield acidification and synthesis method thereof | 山东滨州昱诚化工科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118146259-A | Iron ion stabilizer for oilfield acidification and synthesis method thereof | 山东滨州昱诚化工科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-117430634-A | Iron ion stabilizer for acidizing and fracturing and preparation method thereof | 滨州市广友石油科技有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-117430634-A | Iron ion stabilizer for acidizing and fracturing and preparation method thereof | 滨州市广友石油科技有限公司 | 2024-01-23 | — | — | CN | disclosed |
| US-9265751-B2 | Methods for treating chronic pain | NAGASAKI UNIVERSITY (JP) | 2016-02-23 | — | — | US | disclosed |
| WO-2015193669-A1 | DIAGNOSTIC AND THERAPEUTIC METHOD INVOLVING THE AUTOTAXIN-LYSOPHOSPHATIDIC ACID SIGNALLING PATHWAY | BABRAHAM INSTITUTE (GB) | 2015-12-23 | — | — | WO | disclosed |
| EP-2324852-B1 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR GENERALIZED PAIN SYNDROME | UNIV NAGASAKI (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-20150087812-A1 | Human Autotaxin Antibodies and Methods of Use | JANSSEN BIOTECH, INC. (US) | 2015-03-26 | — | — | US | disclosed |
| EP-2825199-A1 | HUMAN AUTOTAXIN ANTIBODIES AND METHODS OF USE | Janssen Biotech, Inc. (US) | 2015-01-21 | — | — | EP | disclosed |
| EP-0570380-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1993-11-24 | — | — | EP | disclosed |
| WO-1992011268-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1992-07-09 | — | — | WO | disclosed |
| EP-0479813-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES. | HUHTAMAEKI YHTHYMAE OY (FI) | 1992-04-15 | — | — | EP | disclosed |
| WO-1990015806-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | Huhtamäki Oy (FI) | 1990-12-27 | — | — | WO | disclosed |
| US-4579720-A | USING HYDROXYMETHANE DIPHOSPHONIC ACID | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1986-04-01 | — | — | US | disclosed |
| US-4440646-A | HYDROXY OR HALOALKANEPHOSPHONATES | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1984-04-03 | — | — | US | disclosed |
| US-4188234-A | STABILIZATION OF VINYL POLYMERS, POLYPHOSPHONIC ACID CHELATING AGENT, PROTECTIVE COATINGS | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1980-02-12 | — | — | US | disclosed |
| US-4116990-A | OF NON-ALKALI METAL IONS WITH PHOSPHORUS CHELATING COMPOUND | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1978-09-26 | — | — | US | disclosed |
| US-4020091-A | TIN SALTS OF POLYPHOSPHONIC ACIDS | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087812-A1 | Human Autotaxin Antibodies and Methods of Use | ENPP2, PLA2G12A, ABHD16A | KDM4E 3540/4885MMP2 401/4885THRB 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.